KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 153 filers reported holding KURA ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $195,752 | +5.2% | 21,464 | +22.0% | 0.00% | – |
| Q2 2023 | $186,070 | -11.5% | 17,587 | +2.3% | 0.00% | – |
| Q1 2023 | $210,185 | +15.9% | 17,186 | +17.6% | 0.00% | – |
| Q4 2022 | $181,360 | -7.0% | 14,614 | +2.5% | 0.00% | – |
| Q3 2022 | $195,000 | -1.5% | 14,256 | +32.1% | 0.00% | – |
| Q2 2022 | $198,000 | -19.5% | 10,788 | -18.0% | 0.00% | – |
| Q3 2021 | $246,000 | -22.9% | 13,154 | -13.9% | 0.00% | – |
| Q2 2021 | $319,000 | -56.7% | 15,285 | -41.3% | 0.00% | -100.0% |
| Q1 2021 | $737,000 | -17.4% | 26,045 | -4.6% | 0.00% | 0.0% |
| Q4 2020 | $892,000 | +64.6% | 27,303 | +54.2% | 0.00% | – |
| Q3 2020 | $542,000 | – | 17,708 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |